Editors:
first full-length textbook about Fabry disease
includes chapters on the therapeutic management options
complete and stat-of-the-art range of pre-clinical studies
comprehensive chapters on clinical findings
all authors are experts with many years of clinical and research experience
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (32 chapters)
-
Front Matter
-
Pre-Clinical
-
Front Matter
-
-
Clinical
-
Front Matter
-
About this book
Reviews
From the reviews:
“As the first book dedicated to Fabry Disease, this provides an extensive, detailed review of all current information about this rare disorder. … The information presented here will serve genetics specialists in the evaluation, surveillance, and management of affected patients with this rare disorder. … It is also a well-written and informative tool for families affected by this disorder, helping them understand its natural course and available treatment. … This highly specialized, unique book on this rare disorder has no comparison.” (Luis F. Escobar, Doody’s Review Service, March, 2012)Editors and Affiliations
-
, Shaare Zedek Medical Center, Gaucher Clinic, Jerusalem, Israel
Deborah Elstein
-
, Shaare Zedek Medical Center, Genetics Unit, Jerusalem, Israel
Gheona Altarescu
-
University of Mainz, Children's Hospital, Mainz, Germany
Michael Beck
Bibliographic Information
Book Title: Fabry Disease
Editors: Deborah Elstein, Gheona Altarescu, Michael Beck
DOI: https://doi.org/10.1007/978-90-481-9033-1
Publisher: Springer Dordrecht
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer Science+Business Media B.V. 2010
Hardcover ISBN: 978-90-481-9032-4Published: 12 August 2010
Softcover ISBN: 978-94-007-9884-7Published: 29 September 2014
eBook ISBN: 978-90-481-9033-1Published: 02 August 2010
Edition Number: 1
Number of Pages: XXXVII, 512
Topics: Metabolic Diseases, Human Genetics
Industry Sectors: Biotechnology, Health & Hospitals, Pharma